Compounded medication
A compounded medication is one a pharmacy makes to order for a single patient, instead of a product that arrives ready-made from a manufacturer. For a taper that usually means an antidepressant turned into a liquid, or capsules at a small dose no company sells. Compounded medicines are not FDA-approved, so their strength and quality are not checked the way licensed products are. Where a licensed liquid or a lower-strength tablet exists, that is usually the first choice.
Also called: Compounding pharmacy, Compounded antidepressant.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
This page describes US compounding rules: 503A pharmacies and 503B outsourcing facilities. The rules differ in other countries.
What is a compounded medication?
A compounded medication is a medicine a pharmacy makes to order for one patient. The FDA says compounding commonly occurs in pharmacies, so nothing about it is exotic. A compounding pharmacy is a pharmacy that does this work, and for a taper what it usually makes is the liquid your medication does not come in, or a dose smaller than any tablet on the market.
Are compounded antidepressants FDA approved?
No. The FDA puts it plainly: compounded drugs are not FDA-approved, which means the agency does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. That is a statement about who checks the product, not a verdict on the pharmacy. The FDA also names what poor compounding can produce: contamination, or a drug that contains too much or too little active ingredient, which it says can lead to serious patient injury and death.
Who does the checking depends on the kind of pharmacy. A 503A pharmacy makes a preparation for a named patient, and its quality is overseen by the state board of pharmacy. A 503B outsourcing facility registers with the FDA, which inspects it and holds it to the same manufacturing standards as a drug factory. Which one your prescription goes to is a fair question to ask.
The FDA also names the case compounding is for: a patient who cannot be treated with an FDA-approved medication. Asking about an approved product first is therefore the FDA position, not only our advice.
Why would a taper need a compounded medication?
Because the doses a taper ends on are smaller than the tablets on the shelf. Horowitz and Taylor, in The Lancet Psychiatry in 2019, set out hyperbolic tapering for SSRIs: at low doses even a small cut changes the effect a lot, so the last steps have to be finer than the smallest tablet. They also read the research as showing that tapers run over months, down to doses well below the lowest therapeutic one, leave people with fewer withdrawal symptoms than the two to four week tapers in the guidelines.
Sometimes compounding is not needed at all. Several antidepressants have a manufactured liquid in the US. Fluoxetine comes as an oral solution at 20 mg per 5 mL, sertraline as an oral solution with a calibrated dropper, escitalopram as an oral solution as well, and a measured volume of a liquid formulation reaches small doses without any special preparation. Ask about the approved liquid first.
What should you ask before using a compounding pharmacy?
Three questions cover most of it. Whether the pharmacy is a 503A pharmacy or a 503B outsourcing facility. How long each preparation keeps and how to store it. Whether your insurance covers it, and what it costs if not.
Then ask your prescriber to write down how the strength should be stepped down over time, so the pharmacy and the plan say the same thing.
What to do
If compounding turns out to be the answer for you, keep the label from each preparation and write down the date you start a new batch. Note how you feel over the week that follows, so any change has a date next to it. If a new batch feels different from the last one, tell your prescriber and the pharmacy rather than changing anything yourself.
See taper steps for your medication
How withClaro helps
- See what smaller steps look like for your medication
- Log how you feel each day, next to the dose you took
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. FDA, 2024.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 2019.
- U.S. Food and Drug Administration. Fluoxetine oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
All glossary terms